Xometry, Inc. $XMTR Shares Sold by Vanguard Group Inc.

Vanguard Group Inc. cut its holdings in Xometry, Inc. (NASDAQ:XMTR) by 2.6% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 4,094,006 shares of the company’s stock after selling 107,396 shares during the period. Vanguard Group Inc. owned about 0.08% of Xometry worth $223,001,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. PNC Financial Services Group Inc. increased its stake in shares of Xometry by 283.7% in the third quarter. PNC Financial Services Group Inc. now owns 1,508 shares of the company’s stock valued at $82,000 after purchasing an additional 1,115 shares during the period. Peregrine Investment Management Inc. acquired a new position in Xometry during the 3rd quarter worth $4,358,000. Caprock Group LLC bought a new position in shares of Xometry in the third quarter worth $535,000. Versor Investments LP acquired a new position in shares of Xometry during the third quarter valued at $261,000. Finally, Oppenheimer Asset Management Inc. acquired a new stake in Xometry in the third quarter worth about $221,000. 97.31% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, insider Subir Dutt sold 3,929 shares of the stock in a transaction dated Monday, January 5th. The stock was sold at an average price of $65.55, for a total transaction of $257,545.95. Following the transaction, the insider owned 67,419 shares of the company’s stock, valued at approximately $4,419,315.45. This represents a 5.51% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CTO Vaidyanathan Raghavan sold 4,572 shares of the stock in a transaction that occurred on Thursday, February 26th. The shares were sold at an average price of $43.44, for a total value of $198,607.68. Following the transaction, the chief technology officer owned 64,304 shares in the company, valued at approximately $2,793,365.76. This trade represents a 6.64% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 127,852 shares of company stock valued at $6,993,940. Corporate insiders own 9.66% of the company’s stock.

Xometry Trading Down 9.4%

NASDAQ:XMTR opened at $41.01 on Monday. The stock has a market cap of $2.10 billion, a PE ratio of -33.61 and a beta of 0.91. Xometry, Inc. has a fifty-two week low of $18.59 and a fifty-two week high of $73.87. The company has a debt-to-equity ratio of 1.18, a current ratio of 3.76 and a quick ratio of 3.72. The stock’s 50-day moving average is $60.65 and its two-hundred day moving average is $56.14.

Xometry (NASDAQ:XMTR) last issued its earnings results on Tuesday, February 24th. The company reported $0.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.12 by $0.04. Xometry had a negative net margin of 8.99% and a negative return on equity of 5.49%. The company had revenue of $192.40 million during the quarter, compared to analyst estimates of $183.37 million. During the same quarter last year, the business posted $0.06 EPS. The company’s revenue for the quarter was up 29.5% on a year-over-year basis. As a group, equities research analysts forecast that Xometry, Inc. will post -0.66 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of analysts have recently weighed in on the stock. William Blair reaffirmed an “outperform” rating on shares of Xometry in a research note on Tuesday, February 24th. Cantor Fitzgerald lifted their price target on Xometry from $41.00 to $60.00 and gave the company a “neutral” rating in a research report on Wednesday, November 5th. JPMorgan Chase & Co. upped their price objective on Xometry from $55.00 to $70.00 and gave the company an “overweight” rating in a report on Wednesday, November 5th. Royal Bank Of Canada dropped their price target on shares of Xometry from $64.00 to $55.00 and set a “sector perform” rating on the stock in a research report on Wednesday, February 25th. Finally, Zacks Research lowered shares of Xometry from a “hold” rating to a “strong sell” rating in a research report on Friday, January 30th. Five investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $62.00.

More Xometry News

Here are the key news stories impacting Xometry this week:

• Positive Sentiment: Company delivered a solid quarter — revenue grew ~29.5% year‑over‑year and Q4 EPS beat consensus, supporting the long‑term growth story. Read More.
• Positive Sentiment: Management will attend investor conferences (including a March 3 fireside chat), giving investors more access to management and clarity on the upcoming CEO transition. Read More.
• Positive Sentiment: Some firms remain constructive — Citigroup and Wedbush kept buy/outperform stances even while trimming targets, which preserves upside conviction among bullish investors. Read More.
• Neutral Sentiment: A number of analysts adjusted targets with mixed tones — UBS and Royal Bank of Canada moved to neutral/sector‑perform levels, trimming upside but not issuing outright sell calls. This reduces short‑term consensus upside but isn’t uniformly bearish. Read More.
• Neutral Sentiment: Institutional ownership is very high (~97%), so large insider transactions and analyst flows can disproportionately influence intraday liquidity and volatility. Read More.
• Negative Sentiment: Significant, contemporaneous insider selling — CEO, CFO, President, CTO and other insiders reported multi‑thousand‑share sales on Feb. 26. Heavy insider sales on the same day typically spook investors and add downward pressure. Read More.
• Negative Sentiment: Analyst downgrades and target cuts triggered selling flow — several outlets reported the stock drifting lower after the analyst actions, which appears to be a primary catalyst for today’s weakness. Read More.
• Negative Sentiment: Conflicting narratives around the earnings release (some headlines emphasizing the beat, others highlighting margin/negative net income issues) increase short‑term uncertainty and volatility. Read More.

Xometry Profile

Xometry, Inc (NASDAQ: XMTR) operates a technology-driven marketplace that connects businesses with on-demand manufacturing capacity across a wide array of processes. Through its proprietary Instant Quoting Engine and Xometry Platform, the company streamlines sourcing for CNC machining, 3D printing, sheet metal fabrication, injection molding, urethane casting and other custom manufacturing services. By aggregating a network of thousands of vetted suppliers, Xometry offers rapid lead times, transparent pricing and real-time order tracking to customers in sectors ranging from automotive and aerospace to medical devices and industrial equipment.

Since its founding in 2013 and headquarters in Rockville, Maryland, Xometry has expanded its geographic reach to serve customers in North America, Europe and beyond.